Squamous Cell Carcinoma of Head and Neck Clinical Trials in The Bronx, New York

3 studies are recruiting for squamous cell carcinoma of head and neck in The Bronx, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

   This global, open-label, single arm, phase 1b study aims to learn more about whether a treatment called JNJ-90301900 is safe and effective when injected directly into tumors, along with standard chemotherapy and radiation therapy, for participants with head and neck squamous cell cancer (HNSCC; a t…

   Stage

   Phase 1

   Ages

   18 to 74

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   19 in total

   Run by

   Johnson & Johnson Enterprise Innovation Inc.

   See if you can join NCT07219212 on ClinicalTrials.gov

2. A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

   The purpose of this study is to compare anti-tumor activity of amivantamab in addition to pembrolizumab and carboplatin versus pembrolizumab, 5-fluorouracil (FU), and platinum therapy (carboplatin or cisplatin) in participants with refractory/metastatic (R/M) head and neck squamous cell carcinoma (…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   201 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07276399 on ClinicalTrials.gov

3. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

   This trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors. It will study sigvotatug vedotin to find out what its side effects are. A side effect is anything the drug …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, The Bronx, New York

   Locations

   158 in total

   Run by

   Seagen, a wholly owned subsidiary of Pfizer

   See if you can join NCT04389632 on ClinicalTrials.gov